Free Trial

UNITY Biotechnology (UBX) Short Interest Ratio & Short Volume

UNITY Biotechnology logo
$0.18 -0.12 (-40.43%)
Closing price 07/8/2025
Extended Trading
$0.18 0.00 (0.00%)
As of 07/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

UNITY Biotechnology Short Interest Data

UNITY Biotechnology (UBX) has a short interest of 41,000 shares, representing 0.25% of the float (the number of shares available for trading by the public). This marks a -92.84% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 284,137 shares to cover all short positions.

Current Short Interest
41,000 shares
Previous Short Interest
572,500 shares
Change Vs. Previous Month
-92.84%
Dollar Volume Sold Short
$15.75 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
17,212,000 shares
Short Percent of Float
0.25%
Today's Trading Volume
3,732,988 shares
Average Trading Volume
284,137 shares
Today's Volume Vs. Average
1,314%
Short Selling UNITY Biotechnology?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for UNITY Biotechnology and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

UBX Short Interest Over Time

UBX Days to Cover Over Time

UBX Percentage of Float Shorted Over Time

UNITY Biotechnology Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202541,000 shares $15.75 thousand -92.8%0.3%0.1 $0.38
6/15/2025572,500 shares $456.86 thousand -34.4%3.7%1.9 $0.80
5/31/2025873,200 shares $593.78 thousand +16.6%5.6%3 $0.68
5/15/2025749,100 shares $570.07 thousand -11.7%4.8%4.4 $0.76
4/30/2025848,700 shares $959.03 thousand +12.9%5.5%5.2 $1.13
4/15/2025751,600 shares $729.05 thousand +6.6%4.8%3.6 $0.97
3/31/2025704,800 shares $732.99 thousand +10.1%4.6%2.6 $1.04
3/15/2025639,900 shares $1.13 million +15.3%4.2%2.4 $1.77
2/28/2025554,900 shares $948.88 thousand +7.5%3.6%2.3 $1.71
2/15/2025516,300 shares $1.13 million +12.1%3.4%2.2 $2.19
1/31/2025460,400 shares $1.02 million +107.1%3.0%2 $2.22
1/15/2025222,300 shares $375.69 thousand -8.9%1.5%1.1 $1.69
12/31/2024244,000 shares $238.24 thousand -0.9%1.6%1.9 $0.98
12/15/2024246,100 shares $275.63 thousand -4.8%1.6%3.6 $1.12
11/30/2024258,400 shares $320.42 thousand -10.2%1.7%4.6 $1.24
11/15/2024287,600 shares $348.00 thousand -5.1%1.9%5.7 $1.21
10/31/2024303,000 shares $412.08 thousand -0.9%2.0%6.2 $1.36
10/15/2024305,700 shares $427.98 thousand -1.6%2.0%7.5 $1.40
9/30/2024310,700 shares $456.73 thousand +3.0%2.0%7.9 $1.47
9/15/2024301,800 shares $434.59 thousand -8.9%2.0%7.4 $1.44
8/31/2024331,200 shares $539.86 thousand +3.7%2.2%6.5 $1.63
8/15/2024319,500 shares $450.50 thousand +5.5%2.1%5.7 $1.41
7/31/2024303,000 shares $463.59 thousand -2.3%2.0%5.4 $1.53
7/15/2024310,100 shares $483.76 thousand -3.8%2.0%5.4 $1.56
6/30/2024322,200 shares $434.97 thousand 0.0%2.1%5.4 $1.35
6/15/2024322,300 shares $460.89 thousand -3.0%2.1%5.1 $1.43
5/31/2024332,400 shares $515.22 thousand +7.1%2.2%5.5 $1.55
5/15/2024310,300 shares $474.76 thousand -6.1%2.0%3.7 $1.53
4/30/2024330,400 shares $508.82 thousand +8.4%2.2%3.8 $1.54
4/15/2024304,800 shares $457.20 thousand -0.8%2.0%3.4 $1.50
3/31/2024307,200 shares $503.81 thousand +5.4%2.0%3.4 $1.64
3/15/2024291,600 shares $437.40 thousand +0.3%1.9%2.7 $1.50
2/29/2024290,600 shares $531.80 thousand -9.2%1.9%2.6 $1.83
2/15/2024320,000 shares $636.80 thousand +4.5%2.1%3.4 $1.99
1/31/2024306,100 shares $529.55 thousand -0.3%2.0%3.1 $1.73
1/15/2024307,100 shares $571.21 thousand -21.4%2.0%3.2 $1.86
12/31/2023390,700 shares $754.05 thousand -15.6%N/A0 $1.93
12/15/2023463,100 shares $791.90 thousand -7.7%3.1%5.5 $1.71
11/30/2023501,900 shares $963.65 thousand -12.3%3.8%6.9 $1.92
11/15/2023572,500 shares $1.05 million -11.9%4.3%9.1 $1.83
FREE GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad)

With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.

Claim your free copy of “How to Survive the Next Financial Crisis” today
10/31/2023649,600 shares $1.29 million +3.0%4.9%12.8 $1.99
10/15/2023630,900 shares $1.10 million -6.0%4.8%10.3 $1.75
9/30/2023670,900 shares $1.61 million -2.8%5.1%9.7 $2.40
9/15/2023690,400 shares $1.76 million -6.0%5.2%6.6 $2.55
8/31/2023734,600 shares $1.95 million -2.6%5.6%5.9 $2.65
8/15/2023754,500 shares $1.97 million -4.9%5.7%4.6 $2.61
7/31/2023793,500 shares $2.20 million +5.6%6.2%4.3 $2.77
7/15/2023751,800 shares $2.29 million -11.6%5.8%3.4 $3.05
6/30/2023850,300 shares $2.17 million +4.7%6.6%3.1 $2.55
6/15/2023811,900 shares $2.58 million -4.7%6.3%1.9 $3.18
5/31/2023851,900 shares $2.56 million -10.5%6.6%2 $3.01
5/15/2023952,200 shares $2.73 million -17.2%7.4%2.3 $2.87
4/30/20231,150,000 shares $2.46 million -4.2%9.2%2.6 $2.14
4/15/20231,200,000 shares $2.35 million -2.4%9.7%2.7 $1.96
3/31/20231,230,000 shares $2.00 million +21.8%9.9%3 $1.63
3/15/20231,010,000 shares $4.19 million +6.4%8.2%4.1 $4.15
2/28/2023949,000 shares $4.27 million +4.9%7.9%4.1 $4.50
2/15/2023904,900 shares $3.92 million +18.8%7.5%3.8 $4.33
1/31/2023761,600 shares $3.52 million +19.6%5.6%2.9 $4.62
1/15/2023636,700 shares $2.73 million +16.5%4.6%0.9 $4.29
12/30/2022546,500 shares $1.50 million -0.1%4.0%0.8 $2.74
12/15/2022547,000 shares $1.53 million -26.2%4.0%0.8 $2.79
11/30/2022740,900 shares $2.04 million -9.7%5.4%1.1 $2.75
11/15/2022820,100 shares $2.15 million +333.2%6.5%1.2 $2.62
10/31/2022189,300 shares $541.40 thousand +68.3%1.5%0.2 $2.86
10/15/2022112,500 shares $441 thousand -91.4%0.9%0.3 $3.92
9/30/20221,310,000 shares $517.58 thousand -10.9%N/A0.3 $0.40
9/15/20221,470,000 shares $707.07 thousand -17.0%N/A0.4 $0.48
8/31/20221,770,000 shares $822.70 thousand +283.0%N/A0.5 $0.46
8/15/2022462,100 shares $596.11 thousand +31.8%N/A0.1 $1.29
7/31/2022350,600 shares $232.59 thousand +57.0%0.7%0.9 $0.66
7/15/2022223,300 shares $145.15 thousand -38.2%0.4%0.6 $0.65
6/30/2022361,100 shares $203.48 thousand -8.3%0.7%1 $0.56
6/15/2022393,800 shares $234.70 thousand +0.8%0.8%1 $0.60
5/31/2022390,700 shares $308.65 thousand -12.8%0.8%0.8 $0.79
5/15/2022448,000 shares $362.88 thousand -35.5%0.9%0.8 $0.81
4/30/2022694,600 shares $632.09 thousand -19.4%1.4%1.1 $0.91
4/15/2022861,800 shares $887.65 thousand -3.5%1.8%1.2 $1.03
3/31/2022892,700 shares $999.82 thousand +4.4%2.0%1.1 $1.12
3/15/2022855,100 shares $701.18 thousand -20.1%1.9%0.8 $0.82
2/28/20221,070,000 shares $930.90 thousand -8.6%2.8%1 $0.87
2/15/20221,170,000 shares $1.23 million +26.4%3.1%1.1 $1.05
1/31/2022925,400 shares $1.12 million +3.5%2.4%0.7 $1.21
1/15/2022894,100 shares $1.32 million +23.9%2.3%0.7 $1.48
12/31/2021721,600 shares $1.05 million -22.0%1.9%0.7 $1.46
12/15/2021925,100 shares $1.63 million -21.6%2.5%1 $1.76
11/30/20211,180,000 shares $2.60 million -4.1%3.2%1.4 $2.20
11/15/20211,230,000 shares $3.51 million +2.5%3.4%1.6 $2.85
10/29/20211,200,000 shares $2.87 million +1.7%3.4%2.8 $2.39
10/15/20211,180,000 shares $2.77 million -33.3%3.4%3 $2.35
Your Bank Account Is No Longer Safe (Ad)

What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.

Get your free guide now by clicking here >>
9/30/20211,770,000 shares $5.31 million -31.4%5.1%4.6 $3.00
9/15/20212,580,000 shares $7.51 million -2.6%7.4%5.6 $2.91
8/31/20212,650,000 shares $8.48 million -0.8%7.6%5.7 $3.20
8/13/20212,670,000 shares $9.29 million -2.6%7.7%5.5 $3.48
7/30/20212,740,000 shares $9.97 million -9.9%7.9%5.4 $3.64
7/15/20213,040,000 shares $11.83 million +11.8%8.8%5.8 $3.89
6/30/20212,720,000 shares $12.62 million -20.0%7.9%5 $4.64
6/15/20213,400,000 shares $15.16 million +14.9%9.6%7.9 $4.46
5/28/20212,960,000 shares $13.26 million +11.3%8.4%7.1 $4.48
5/14/20212,660,000 shares $11.33 million +11.8%7.6%6 $4.26
4/30/20212,380,000 shares $12.14 million -8.5%7.8%4 $5.10
4/15/20212,600,000 shares $14.59 million +28.1%8.6%3.9 $5.61
3/31/20212,030,000 shares $11.65 million -12.5%6.9%2.7 $5.74
3/15/20212,320,000 shares $16.26 million +9.4%7.9%2.7 $7.01
2/26/20212,120,000 shares $14.37 million -12.4%7.4%2.3 $6.78
2/12/20212,420,000 shares $20.04 million -12.6%8.5%2.5 $8.28
1/29/20212,770,000 shares $16.45 million -9.2%9.5%3.2 $5.94
1/15/20213,050,000 shares $21.75 million -5.0%10.6%3.8 $7.13
12/31/20203,210,000 shares $17.17 million -0.6%10.6%4.2 $5.35
12/15/20203,230,000 shares $19.19 million +1.9%10.7%4.6 $5.94
11/30/20203,170,000 shares $20.16 million +1.3%11.3%4.1 $6.36
10/30/20202,730,000 shares $11.55 million -10.2%10.1%1.8 $4.23
10/15/20203,040,000 shares $11.89 million -8.2%11.4%1.8 $3.91
9/30/20203,310,000 shares $11.45 million -6.0%12.4%2 $3.46
9/15/20203,520,000 shares $12.43 million -1.4%13.2%2.2 $3.53
8/31/20203,570,000 shares $11.21 million -40.6%12.8%2.4 $3.14
8/14/20206,010,000 shares $74.70 million +11.7%22.8%4.4 $12.43
7/31/20205,380,000 shares $50.73 million +6.1%20.4%9.9 $9.43

UBX Short Interest - Frequently Asked Questions

What is UNITY Biotechnology's current short interest?

Short interest is the volume of UNITY Biotechnology shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 41,000 shares of UBX short. 0.25% of UNITY Biotechnology's shares are currently sold short. Learn More on UNITY Biotechnology's current short interest.

Which institutional investors are shorting UNITY Biotechnology?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of UNITY Biotechnology: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for UNITY Biotechnology?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.25% of UNITY Biotechnology's floating shares are currently sold short.

Is UNITY Biotechnology's short interest increasing or decreasing?

UNITY Biotechnology saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 41,000 shares, a drop of 92.8% from the previous total of 572,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does UNITY Biotechnology's short interest compare to its competitors?

0.25% of UNITY Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to UNITY Biotechnology: IM Cannabis Corp. (12.28%), AlloVir, Inc. (2.56%), Phio Pharmaceuticals Corp. (7.19%), BioXcel Therapeutics, Inc. (6.08%), Ainos, Inc. (4.92%), Cyclerion Therapeutics, Inc. (1.49%), NKGen Biotech, Inc. (1.16%), Lixte Biotechnology Holdings, Inc. (8.49%), Imunon, Inc. (6.13%), Sensei Biotherapeutics, Inc. (1.69%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short UNITY Biotechnology stock?

Short selling UBX is an investing strategy that aims to generate trading profit from UNITY Biotechnology as its price is falling. UBX shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against UNITY Biotechnology?

A short squeeze for UNITY Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of UBX, which in turn drives the price of the stock up even further.

How often is UNITY Biotechnology's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UBX, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:UBX) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners